A New Medicine on Horizon for Patients with IBS

Sucampo Pharmaceuticals submitted a supplemental new drug application to the FDA to market their drug, Amitiza®, currently used for chronic constipation, to patients with IBS with constipation. Clinical trials have shown that patients receiving lubiprostone were twice as likely to achieve an overall response Medical News Today.
2007-10-10 12:31:37